http://streetinsider.com Latest StreetInsider.com News Articles en-us Copyright 2026, StreetInsider.com rss@streetinsider.com (SI RSS) rss@streetinsider.com (SI RSS) Fri, 05 Jun 2026 08:01:00 -0400 http://blogs.law.harvard.edu/tech/rss http://www.streetinsider.com/images/rss_logo.gif http://streetinsider.com 143 28 0 1 2 3 21 22 23 Saturday Sunday http://www.streetinsider.com/Press+Releases/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html <p>DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha&apos;s Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company&apos;s common stock in connection with their employment. The RSUs and stock option were granted under http://www.streetinsider.com/Press+Releases/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html Fri, 05 Jun 2026 08:01:00 -0400 O.47603234 TSHA http://www.streetinsider.com/Press+Releases/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html <p>DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha&apos;s Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company&apos;s common stock in connection with their employment. The RSUs and stock option were granted under http://www.streetinsider.com/Press+Releases/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html Fri, 05 Jun 2026 08:01:00 -0400 O.47603234 TSHA http://www.streetinsider.com/Globe+Newswire/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html <p>DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha&apos;s Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company&apos;s common stock in connection with their employment. The RSUs and stock option were granted under http://www.streetinsider.com/Globe+Newswire/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html Fri, 05 Jun 2026 08:01:00 -0400 O.47603234 TSHA http://www.streetinsider.com/Globe+Newswire/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html <p>DALLAS, June 05, 2026 (GLOBE NEWSWIRE) -- Taysha Gene Therapies, Inc. (Nasdaq: TSHA) (Taysha or the Company), a clinical-stage biotechnology company focused on advancing adeno-associated virus (AAV)-based gene therapies for severe monogenic diseases of the central nervous system (CNS), today announced that, on June 1, 2026, the Compensation Committee of Taysha&apos;s Board of Directors granted four new employees, in the aggregate, restricted stock units (RSUs) representing 714,700 shares of the Company’s common stock and an option to purchase 468,600 shares of the Company&apos;s common stock in connection with their employment. The RSUs and stock option were granted under http://www.streetinsider.com/Globe+Newswire/Taysha+Gene+Therapies+Announces+Inducement+Grant+Under+Nasdaq+Listing+Rule+5635%28c%29%284%29/26608497.html Fri, 05 Jun 2026 08:01:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Stalfort+John+A+III/26592234.html si-local-file:///var/storage/secattach/20260602/26592234.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Stalfort+John+A+III/26592234.html Tue, 02 Jun 2026 16:31:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Stalfort+John+A+III/26592234.html si-local-file:///var/storage/secattach/20260602/26592234.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Stalfort+John+A+III/26592234.html Tue, 02 Jun 2026 16:31:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Donenberg+Phillip+B./26592218.html si-local-file:///var/storage/secattach/20260602/26592218.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Donenberg+Phillip+B./26592218.html Tue, 02 Jun 2026 16:30:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Donenberg+Phillip+B./26592218.html si-local-file:///var/storage/secattach/20260602/26592218.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Donenberg+Phillip+B./26592218.html Tue, 02 Jun 2026 16:30:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Long+Alison+S/26592223.html si-local-file:///var/storage/secattach/20260602/26592223.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Long+Alison+S/26592223.html Tue, 02 Jun 2026 16:30:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Long+Alison+S/26592223.html si-local-file:///var/storage/secattach/20260602/26592223.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Long+Alison+S/26592223.html Tue, 02 Jun 2026 16:30:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Sepp-Lorenzino+Laura/26592230.html si-local-file:///var/storage/secattach/20260602/26592230.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Sepp-Lorenzino+Laura/26592230.html Tue, 02 Jun 2026 16:30:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Sepp-Lorenzino+Laura/26592230.html si-local-file:///var/storage/secattach/20260602/26592230.html http://www.streetinsider.com/SEC+Filings/Form++4++++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01++Filed+by%3A+Sepp-Lorenzino+Laura/26592230.html Tue, 02 Jun 2026 16:30:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01/26591576.html si-local-file:///var/storage/secattach/20260602/26591576.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01/26591576.html Tue, 02 Jun 2026 16:06:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01/26591576.html si-local-file:///var/storage/secattach/20260602/26591576.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+Jun+01/26591576.html Tue, 02 Jun 2026 16:06:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26507810.html si-local-file:///var/storage/secattach/20260515/26507810.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26507810.html Fri, 15 May 2026 17:13:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26507810.html si-local-file:///var/storage/secattach/20260515/26507810.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+Vestal+Point+Capital%2C+LP/26507810.html Fri, 15 May 2026 17:13:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26500183.html si-local-file:///var/storage/secattach/20260515/26500183.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26500183.html Fri, 15 May 2026 08:36:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26500183.html si-local-file:///var/storage/secattach/20260515/26500183.html http://www.streetinsider.com/SEC+Filings/Form++SCHEDULE+13GA++Taysha+Gene+Therapies%2C+++++++++++++++++Filed+by%3A+RTW+INVESTMENTS%2C+LP/26500183.html Fri, 15 May 2026 08:36:00 -0400 O.47603234 TSHA http://www.streetinsider.com/Analyst+PT+Change/Taysha+Gene+Therapies+%28TSHA%29+PT+Raised+to+%2410+at+BMO+Capital/26448545.html BMO Capital analyst Evan Seigerman raised the price target on Taysha Gene Therapies (NASDAQ: TSHA) to $10.00 (from $8.00) while maintaining a Outperform rating. http://www.streetinsider.com/Analyst+PT+Change/Taysha+Gene+Therapies+%28TSHA%29+PT+Raised+to+%2410+at+BMO+Capital/26448545.html Thu, 07 May 2026 07:46:52 -0400 TSHA http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Taysha+Gene+Therapies%2C++++For%3A+Mar+31/26439865.html si-local-file:///var/storage/secattach/20260506/26439865.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Taysha+Gene+Therapies%2C++++For%3A+Mar+31/26439865.html Wed, 06 May 2026 08:31:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Taysha+Gene+Therapies%2C++++For%3A+Mar+31/26439865.html si-local-file:///var/storage/secattach/20260506/26439865.html http://www.streetinsider.com/SEC+Filings/Form++10-Q+++++++Taysha+Gene+Therapies%2C++++For%3A+Mar+31/26439865.html Wed, 06 May 2026 08:31:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+May+06/26439624.html si-local-file:///var/storage/secattach/20260506/26439624.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+May+06/26439624.html Wed, 06 May 2026 08:12:00 -0400 O.47603234 TSHA http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+May+06/26439624.html si-local-file:///var/storage/secattach/20260506/26439624.html http://www.streetinsider.com/SEC+Filings/Form++8-K++++++++Taysha+Gene+Therapies%2C++++For%3A+May+06/26439624.html Wed, 06 May 2026 08:12:00 -0400 O.47603234 TSHA http://www.streetinsider.com/Earnings/Taysha+Gene+Therapies+%28TSHA%29+Misses+Q1+EPS+by+2c/26439525.html <p>Taysha Gene Therapies (NASDAQ: TSHA) reported Q1 EPS of ($0.12), $0.02 worse than the analyst estimate of ($0.10).</p><p>For earnings history and earnings-related data on Taysha Gene Therapies (TSHA) <a href="http://www.streetinsider.com/ec_earnings.php?q=TSHA">click here</a>.</p> http://www.streetinsider.com/Earnings/Taysha+Gene+Therapies+%28TSHA%29+Misses+Q1+EPS+by+2c/26439525.html Wed, 06 May 2026 08:03:21 -0400 TSHA http://www.streetinsider.com/Press+Releases/Taysha+Gene+Therapies+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26439436.html <table style="border-collapse: collapse; width:100%; border-collapse:collapse ;"><tr><td style="max-width:100%; width:100%; min-width:100%;;padding-left: 0 ; padding-right: 0 ; text-align: center ; vertical-align: middle; vertical-align: bottom ; "><em>Reaffirmed FDA alignment on TSHA-102 BLA pathway, including pivotal trial design, endpoints and potential to submit for approval based on REVEAL pivotal trial 6-month interim analysis, following recent breakthrough therapy Type B meeting</em></td></tr><tr><td style="padding-left: 0 ; padding-right: 0 ; text-align: center ; vertical-align: middle; vertical-align: bottom ; "> </td></tr><tr><td style="padding-left: 0 ; padding-right: 0 ; text-align: center ; vertical-align: middle; vertical-align: bottom ; "><em>Further advanced dosing in the REVEAL pivotal trial, with enrollment in the ASPIRE http://www.streetinsider.com/Press+Releases/Taysha+Gene+Therapies+Reports+First+Quarter+2026+Financial+Results+and+Provides+Corporate+Update/26439436.html Wed, 06 May 2026 08:00:00 -0400 A.06822034 A.26566475 O.07320020 O.20026344 O.47603234 TSHA